Results
Bafna Pharmaceuticals FY26 Net Profit Up 167% YoY
Bafna Pharmaceuticals disclosed its Annual Report for FY 2025-26 under SEBI Regulation 34(1), reporting a 167% YoY surge in net profit to ₹111 million.
The company announced its 31st AGM will be held
